EVAN HATFILL: Open Payments
NPI 1679175996 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,838 in 128 payments from 20 companies in 2025. Trend: 2023 $4,048 · 2024 $2,986 · 2025 $3,838
Food & beverage: $3,726Education: $112
| Company | Payments | Amount |
|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | 13 | $599 |
| Novartis Pharmaceuticals Corporation | 19 | $555 |
| Galderma Laboratories, L.P. | 11 | $520 |
| ABBVIE INC. | 14 | $370 |
| Janssen Biotech, Inc. | 19 | $366 |
| Regeneron Healthcare Solutions, Inc. | 11 | $290 |
| UCB, Inc. | 8 | $230 |
| GENZYME CORPORATION | 5 | $229 |
| Lilly USA, LLC | 3 | $139 |
| Organon LLC | 9 | $114 |
Products named: DUPIXENT, NEMLUVIO, ILUMYA, TREMFYA, COSENTYX, SKYRIZI, Bimzelx, Rhapsido.
Industry payments across TN — which companies pay providers there.
